Euglena
VC Fund
Tokyo, Japan
Euglena is a VC fund in Tokyo focused on Health Care and Biotechnology. euglena Co., Ltd. engages in the research, development, production, and sale of microalgae with a focus on euglena. The company also manufactures and sells foods and cosmetics using euglena. It offers green juices, cookie bars, beverages, dietary supplements, and raw materials, as well as contract manufacturing/processing services; and skincare products.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Euglena invests in
Stages Euglena invests in
Countries Euglena invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 11 contacts → | |||
Round size
- Seed
- $527k–$3.7M
- Series A
- $2.2M–$5.6M
Investment Focus
Industry
- Health Care 4 (40%)
- Biotechnology 3 (30%)
- Food and Beverage 3 (30%)
- Beauty 2 (20%)
- Snack Food 2 (20%)
Stage
- Seed 4 (40%)
- Series A 3 (30%)
- Venture - Series Unknown 2 (20%)
- Corporate Round 1 (10%)
Country
- Japan 9 (90%)
- United States 1 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Mitsuru Izumo
Founder and CEO
|
Founder and CEO | Total investments: 1 | Find email | |
Akihiko Nagata
Executive Vice President COO
|
Executive Vice President COO | Total investments: 10 | Find email | |
Daisuke Susa
Executive Officer
|
Executive Officer | Total investments: 0 | Find email | |
Etsuko Okajima
Director (Outside Director)
|
Director (Outside Director) | Total investments: 1 | Find email | |
Junnosuke Awa
Executive Officer
|
Executive Officer | Total investments: 0 | Find email | |
| See all 11 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| MisakyTokyo provides food and beverage services. | $3.7M / Seed / Nov 21, 2023 | ||
| KAICO is a pharmaceuticals, diagnostic drugs production company. | $2.3M / Series A / Dec 15, 2021 | ||
| Minimal - Bean to Bar Chocolate sells cacao beans and handmade chocolate. Their product line includes chocolate rare cheesecake, cacao tours, chocolate bars, sweets, chocolate sandwich cookies, and sweets. Their products serve consumers. | Venture - Series Unknown / Jul 13, 2020 | ||
| NeuroSpace is a science venture that leads human's 24 hours to a new level with Neuroscience Technology, which elucidates the mystery of sleep . | $2.2M / Series A / Apr 08, 2019 | ||
| Jeplan develops and applies chemical recycling technologies focused on polyethylene terephthalate (PET) materials used in products such as plastic bottles and polyester textiles. The company’s activities include recycling waste PET at the molecular level to produce recycled raw materials, operating recycling facilities, and licensing relatedtechnologies. It also conducts programs for collecting used clothing and plastics, producing recycled materials, and supporting resource circulation systems across supply chains. | Corporate Round / Jun 21, 2018 | ||
| Integriculture makes cellular agriculture products to improve sustainability, food security, and reduce public health problems. The company offers a developed patented general-purpose large-scale cell culture system that can culture wide range of cells without external addition of expensive growth factors and provide consumers with affordable cleanmeat.Founded in 2015, Integriculture is headquartered in Tokyo, Japan. | $2.7M / Seed / May 25, 2018 | ||
| Medcare is a medical service corporation. | $5.6M / Series A / Apr 27, 2018 | ||
| Pocket Marche is a smartphone app that allows you to buy food while talking with farmers and fishermen across the country. | $1.6M / Seed / Sep 29, 2017 | ||
| Amelieff provides bioinformatic skills and knowledge to help bio-researchers. The company's bioinformaticians analyzes data by using open-source software and in-house developed tools. The company delivers data analysis servers made of widely used bioinformatics software. Servers may be customized on request, such as organisms’ genome. Thecompany also offers bioinformatics skill training. Training can be at a desired site and schedule, and the contents may be customized to customers demands.Amelieff was founded in July 2009 and is headquartered in Tokyo, Japan. | $437.6K / Venture - Series Unknown / Feb 15, 2016 | ||
| Meltin MMI is a cyborg-technology company that focuses on biosensors and robotic arms. Meltin has successfully enabled fine finger movements, such as for amputees and participated in Cybathlon 2016 and won the Microsoft Innovation Award. | $526.6K / Seed / Feb 15, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Euglena invest in?
Euglena invests primarily in Health Care, Biotechnology and Food and Beverage startups, most often at Seed and Series A stage. Most of the 10 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Euglena invest in?
Euglena typically joins rounds of $527k–$3.7M at Seed and $2.2M–$5.6M at Series A. These are whole funding-round sizes, not Euglena's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Euglena took part in.
How do I contact Euglena?
Public channels for Euglena include X (Twitter), the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Euglena?
The team at Euglena includes Mitsuru Izumo (Founder and CEO), Akihiko Nagata (Executive Vice President COO) and Daisuke Susa (Executive Officer), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
